What is the recommended infusion rate for maintaining sedation with ketamine (intravenous anesthetic agent)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ketamine Infusion Rate for Maintaining Sedation

For maintaining sedation with intravenous ketamine, administer a continuous infusion at 0.1 to 0.5 mg/kg/hour (or 1.7 to 8.3 mcg/kg/min), which will maintain general anesthesia in adult patients following ketamine induction. 1

Initial Bolus Dosing

Before starting a maintenance infusion, administer an appropriate induction dose:

  • Give 1.5-2 mg/kg IV as the initial bolus over 60 seconds, which produces 5-10 minutes of surgical anesthesia within 30 seconds and requires significantly fewer supplemental doses compared to lower dosing (only 5.5% of patients require additional ketamine versus 54% with 1.0 mg/kg). 2, 1

  • Rapid administration should be avoided as it may result in respiratory depression and enhanced vasopressor response. 1

Maintenance Infusion Protocols

Standard Maintenance Approach

  • Administer ketamine by slow microdrip infusion at 0.1 to 0.5 mg/minute (equivalent to approximately 0.1-0.5 mg/kg/hour in a 70kg adult) to maintain general anesthesia. 1

  • For preparation, dilute ketamine to create a 1 mg/mL solution by transferring 10 mL from a 50 mg/mL vial or 5 mL from a 100 mg/mL vial to 500 mL of 5% Dextrose or Normal Saline, and use immediately after dilution. 1

Alternative Dosing Regimens

  • For critically ill patients requiring prolonged sedation, start with 1 mg/kg IV bolus followed by continuous infusion at 1.0 mg/kg/hour, then titrate in increments of 0.5 mg/kg/hour every 30 minutes until achieving adequate sedation (Ramsay score of 4). 3

  • The mean maintenance dose in ICU patients is approximately 2.25 mg/kg/hour, with plasma concentrations around 3 mcg/mL and recovery time averaging 168 minutes after cessation. 3

Combination Therapy Considerations

  • Consider adding midazolam 0.05-0.1 mg/kg IV to reduce emergence reactions and recovery agitation, particularly in patients over 10 years old (reduces agitation from 35.7% to 5.7%). 2

  • When combining ketamine with midazolam for ICU sedation, use ketamine 1 mg/kg bolus followed by 1.0 mg/kg/hour infusion with midazolam 0.1 mg/kg bolus and 0.05 mg/kg/hour infusion. 3

  • Concurrent administration of ketamine with intravenous lidocaine is acceptable and has often been used in patients with difficult-to-manage pain. 4

Monitoring Requirements

  • Continuously monitor vital signs including ECG, pulse oximetry, and blood pressure throughout ketamine administration, as care consistent with general anesthesia is required. 5

  • Maintain vascular access throughout the procedure until the patient is no longer at risk for cardiorespiratory depression. 5

  • Emergency airway equipment must be immediately available, and practitioners must be able to rescue patients from unintended deep sedation. 5

Duration and Recovery Expectations

  • Average total sedation time with IV ketamine is approximately 75-78 minutes, with recovery time averaging 84 minutes (range 22-215 minutes). 2

  • Plasma half-life of ketamine is approximately 1 hour, with rapid decrease in plasma concentrations after cessation of infusion. 3

Common Pitfalls and Safety Considerations

  • Do NOT continue ketamine infusion into the postoperative period, as this increases risk of hallucinations without significantly enhancing analgesic effect. 5

  • Hypoxemia occurs in 1.6-7.3% of patients and is typically transient and responsive to supplemental oxygen, though bag-valve-mask ventilation may be required in approximately 2% of cases. 2

  • Recovery agitation occurs in approximately 17.6% of patients (mild) and 1.6% (moderate-to-severe), which may require treatment with benzodiazepines. 2

  • Administer an antisialagogue prior to induction due to potential for increased salivation during ketamine administration. 1

Contraindications

  • Avoid ketamine in patients with uncontrolled cardiovascular disease, cerebrovascular disease, active psychosis, severe hepatic dysfunction, elevated intracranial or intraocular pressure, or pregnancy. 2, 5

  • Ketamine causes dose-dependent increases in heart rate, blood pressure, and cardiac output through sympathetic nervous system stimulation. 2

References

Guideline

Ketamine Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guidelines for Safe Administration of Ketamine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.